Stay updated on Pevonedistat Combination in AML Clinical Trial
Sign up to get notified when there's something new on the Pevonedistat Combination in AML Clinical Trial page.

Latest updates to the Pevonedistat Combination in AML Clinical Trial page
- CheckyesterdayChange DetectedNew revision entry added: Revision: v3.3.3 is now listed in the study history. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed from the page footer/history.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows Revision: v3.3.2 in the footer, and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved a site-wide government funding/operating status notice previously shown on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check59 days agoChange DetectedThe new screenshot shows updates to Study Status, Recruitment Status, IPDSharing, and other record sections across multiple history entries. These changes reflect the trial's progression and data-sharing status in the record.SummaryDifference0.1%

- Check80 days agoChange DetectedMajor change: page now advertises a government operating status notice and updates to version v3.2.0; previous v3.1.0 tag has been removed.SummaryDifference11%

- Check87 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0 to reflect a new release.SummaryDifference0.3%

Stay in the know with updates to Pevonedistat Combination in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pevonedistat Combination in AML Clinical Trial page.